Healwell AI Secures Strategic Foothold in Middle East, Signaling Global Ambitions

Healwell AI secures a landmark Middle East contract and reports a 354% revenue surge to $30.4M in Q3 2025, achieving positive adjusted EBITDA and a $120M annualized run rate.

Shares of Canadian healthcare artificial intelligence specialist Healwell AI traded higher following the company's announcement of a landmark contract in the Middle East. This move marks a significant step in the firm's international expansion strategy beyond its core North American markets. Concurrently, management has scheduled appearances at three major investor conferences in March 2026, underscoring its commitment to transitioning from a loss-making startup to a profitable AI platform provider.

Financial Restructuring Bears Fruit

The commercial momentum is underpinned by a fundamental corporate turnaround. For the third quarter of 2025, Healwell reported revenue of $30.4 million from continuing operations—a substantial 354% increase compared to the $6.7 million generated in the same period the prior year. This dramatic growth is largely attributed to the completed acquisition of Orion Health on April 1, 2025, which granted the company access to over 150 million patient lives globally.

A critical financial milestone was reached: Healwell posted an adjusted EBITDA of $0.7 million in Q3 2025, a notable reversal from a $2.8 million loss in the previous year's quarter. This represented the company's second consecutive quarter of positive adjusted EBITDA. The current annualized revenue run rate now stands at approximately $120 million.

Geographic Expansion Accelerates

On February 26, 2026, Healwell AI announced its first contracted AI implementation in the Middle East via the Orion Health network. This development, alongside expanded active deployments in Canada and the United States, demonstrates the scalability and international appeal of its platform. The company's products—SMART Identify, SMART Search, and SMART Summary—are now operational across multiple health systems.

Headquartered in Toronto, Healwell now boasts contractually secured revenue streams across three continents and reports a growing pipeline for additional enterprise rollouts. The Middle East agreement is particularly significant, breaking the company's historical focus on North America.

A Busy Month for Investor Outreach

Healwell is leveraging March 2026 for a targeted communications campaign with the investment community. The management team is set to present at the TD Cowen conference in Boston (March 2-4), the Scotiabank TMT Conference in Toronto (March 3-4), and the ROTH Conference in Dana Point (March 22-24).

A fireside chat is scheduled for 11:35 AM ET today, March 4, at the Scotiabank event. Later this month, at the ROTH Conference, CEO Dr. Alexander Dobranowski will participate in a panel discussion titled "Technologies Advancing Healthy Aging." He will be joined by executives from HeartBeam, Niagen Bioscience, and Rapalogix, with a focus on AI-powered early detection and extending health spans.

Platform Integration and New Launch

Technologically, Healwell has consolidated the AI capabilities from its Khure and Pentavere acquisitions into a unified AI engine powered by its proprietary DARWEN™ technology. The company plans the North American launch of its Amadeus AI platform in the first half of 2026, with an international expansion slated for late 2026.

Strategic Alliance with WELL Health

On February 19, 2026, Healwell AI and WELL Health Technologies Corp. jointly launched the WELLTRUST™ platform. Currently deployed in WELL-operated clinics across Canada, the platform empowers patients to control consent for the use of their health data. Utilizing the DARWEN™ AI, WELLTRUST identifies suitable candidates for clinical trials while maintaining strict adherence to privacy regulations and compliance standards. The platform integrates consent management, unified privacy controls, and AI-driven recruitment.

WELL Health holds approximately 69% of the voting rights and a 37% economic interest in Healwell. This strategic alliance is designed to accelerate the scaling of AI-powered health technologies.

Outlook: Growth Amidst Recognized Challenges

As Healwell enters the second quarter of 2026, it does so with its broadest geographic footprint to date. Its DARWEN™-powered AI suite is active on three continents, platform integration is progressing, and investor engagement is intensifying. The company acknowledges that regulatory hurdles, potential delays in clinical adoption, and the complexity of international data privacy laws could present headwinds to growth. Nevertheless, its focus on scalable SaaS and AI solutions positions it to capitalize on the ongoing digital transformation within the global healthcare sector.